LAS-103

N/A

Report date: 2024/11/29 15:07:56
NME

Base Information

Drug NameLAS-103
Drug Alias NameLAS-103
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionEndothelin receptor type B antagonists
TargetsEndothelin receptor type B
Therapy Area/IndicationsOvarian NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLassogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesLassogen Inc
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A